Riskpilot← Back to searchSign inGet full accessByrologen AB
ABActiveOrg 5591082275Lungviksvägen 27Other human health activities n.e.c. · NACE 8699Est. 20171 employees
Revenue 2024
SEK 425K
EBITDA margin
18.6%
+183% vs 2023
Equity ratio
-45.7%
Financial strength
Net profit 2024
SEK 68K
+118% vs 2023
| Revenue | SEK 425K | — |
| EBITDA | SEK 79K | +183% |
| Net profit | SEK 68K | +118% |
| Total assets | SEK 335K | +415% |
| Equity | SEK -153K | +31% |
| Employees | 1 | — |
Legal name
Byrologen AB
Org number
5591082275
Legal form
Aktiebolag
NACE code
8699 · Other human health activities n.e.c.
Founded
7 april 2017
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva psykologiska utredningar, personalutveckling, personalutbildning och handledning inom dessa områden samt handel med värdepapper och fast egendom och därmed förenlig verksamhet.
Address
Lungviksvägen 27
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 138 | 116 | 0 | 0 | 425 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 102 | 61 | −87 | −95 | 79 |
| Depreciation & amort. | −0 | −9 | −10 | −10 | −10 |
| EBIT | 102 | 52 | −97 | −105 | 69 |
| Net financials | — | — | — | −565 | −1 |
| Profit before tax | 102 | 47 | −92 | −388 | 68 |
| Tax | −22 | −10 | −0 | −0 | −0 |
| Net profit | 80 | 37 | −92 | −388 | 68 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 457 | 447 | 350 | 65 | 335 |
| Equity | 222 | 259 | 167 | −221 | −153 |
| Long-term debt | 0 | 0 | 178 | 267 | 341 |
| Short-term debt | 236 | 183 | 5 | 19 | 146 |
| Total debt | 236 | 183 | 183 | 286 | 487 |
EBITDA margin
18.6%
This company
15.8%
Market median
+18% vs market
20202024
Equity ratio
-45.7%
This company
38.2%
Market median
-220% vs market
20202024
Return on equity
6800000.0%
This company
18.4%
Market median
+36956422% vs market
20202024
Net profit margin
16.0%
This company
8.1%
Market median
+98% vs market
20202024
Asset turnover
1.27×
This company
1.12×
Market median
+13% vs market
20202024
Debt / equity
3.19×
This company
0.62×
Market median
-415% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Byrologen AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anna-Karin Elisabeth Skoglund | Deputy Board Member | 0 companies |
| John Runar Skoglund | Board of Directors | 0 companies |